Is Israel ready for disease management?

Israel Medical Association Journal

Volumn 8, Issue 10, 2006, Pages 667-671

  Linden, Ariel ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Linden Consulting Group ^*  (United States)

^c LINDEN CONSULTING GROUP   (United States)

Author keywords

Chronic illness; Disease management; Healthcare system; Israel

Indexed keywords

ARTICLE; BEHAVIOR MODIFICATION; CAUSE OF DEATH; CHRONIC DISEASE; DECISION MAKING; FUNDING; GOVERNMENT REGULATION; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH PROGRAM; HOSPITAL CHARGE; INVESTMENT; ISRAEL; MEDICAID; PATIENT CARE; POPULATION RESEARCH; REIMBURSEMENT; SOCIAL SECURITY; TAX;

ADULT; AGED; CHRONIC DISEASE; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; ISRAEL; MALE; MIDDLE AGED; PHYSICIAN'S ROLE; PREVENTIVE MEDICINE; PROGRAM EVALUATION; UNITED STATES;

EID: 33750691041     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. World Health Organization. Preventing Chronic Diseases: A Vital Investment. Geneva: World Health Organization, 2005.
2. Partnership for Solutions. Chronic Conditions: Making the Case for Ongoing Care - September 2004 Update. Available from URL: http://www.rwjf.org/research/researchdetail.jsp?id=1502&ia=142. [Accessed 7 Jan 2006]
3. National Center for Health Statistics. Health, United States, 2005: with chartbook on trends in the health of Americans. Hyattsville, MD, 2005.
4. Brodsky J. The challenges of success: the aging of Israeli society. JMAJ 2003;(5):375-8.
5. McDevitt TM, Rowe PM. The United States in International Context: 2000. Census 2000 Brief, C2KBR/01-11. Washington, DC: U.S. Census Bureau, 2002.
6. Hetzel L, Smith A. The 65 years and older population: 2000. Census 2000 Brief, C2KBR/01-10. Washington, DC: U.S. Census Bureau. October 2001.
7. Gist YJ, Hetzel LI. We the People: Aging in the United States: Census 2000 Special Reports, CENSR-19. Washington, DC: U.S. Census Bureau. December 2004.
8. World Health Organization. The World Health Report 2000. Geneva: World Health Organization, 2005.
9. Stern SM, Waldrop J. Disability: 2000; Census 2000 Brief, C2KBR-17. Washington, DC: U.S. Census Bureau, March 2003.
10. Matheson D, Robinson T. Disease Management Takes Flight. Boston, MA: The Boston Consulting Group, October 2000.
11. Linden A, Adams J, Roberts N. Evaluation methods in disease management: determining program effectiveness. Position Paper for the Disease Management Association of America (DMAA), October 2003.
12. Ellrodt G, Cook DJ, Lee J, Cho M, Hunt D, Weingarten S. Evidence-based disease management. JAMA 1997;278(20):687-92.
13. Hunter DJ, Fairfield G. Disease management. Br Med J 1997;315: 50-3.
14. Disease Management Association of America. Definition of disease management. Available from URL: http://www.dmaa.org/definition.html. [Accessed 7 Jan 2006].
15. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. Br Med J 2002;325(7370):925-32.
16. Congressional Budget Office. An Analysis of the Literature on Disease Management Programs. Washington DC: Congressional Budget Office. 13 October 2004. Located at: http://www.cbo.gov/ showdoc.cfm?index=5909&sequence=0. [Accessed 7 Jan 2006].
17. Ofman JJ, Badamgarav E, Henning JM, et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med 2004;117(3):182-92.
18. Knight K, Badamgarav E, Henning JM, et al. A systematic review of diabetes disease management programs. Am J Manag Care 2005;111(4):242-50.
19. Krause DS. Economic effectiveness of disease management programs: a meta-analysis. Dis Manage 2005;(8):114-34.
20. Goetzel RZ, Ozminkowski RJ, Villagra VG, Duffy J. Return on investment on disease management: a review. Health Care Fin Rev 2005;26:1-19.
21. Linden A. What will it take for disease management to demonstrate a return on investment? New perspectives on an old theme. Am J Manage Care 2006;12(4):61-7.
22. Chinitz D. Israel's health policy breakthrough: The politics of reform and reform of politics. J Health Polit Policy Law 1995;20:909-32.
23. DeNavas-Walt C, Proctor BD, Lee CH. U.S. Census Bureau, Current Population Reports, P60-229, Income, Poverty, and Health Insurance Coverage in the United States: 2004, U.S. Government Printing Office, Washington, DC, 2005.
24. Crippen DL. Disease Management in Medicare: Data Analysis and Benefit Design Issues: A CBO testimony before the Special Committee on Aging: United States Senate. Washington DC: Congressional Budget Office. 19 September 2002. Located at: http://www.cbo.gov/ showdoc.cfm?index=3776&sequence=0. [Accessed 18 Mar 2006].
25. Busse R. Disease management programs in Germany's Statutory Health Insurance system. Health Affairs 2004;23(3):56-67.
26. Linden A, Roberts N, Keck K. The complete "how to" guide for selecting a disease management vendor. Dis Manage 2003;6(1):21-6.
27. Linden A, Roberts N. Disease management interventions: What's in the black box? Dis Manage 2004;7(4):275-91.
28. Linden A, Butterworth SW, Roberts N. Disease management interventions. II: What else is in the black box? Dis Manage 2006;9(2):73-85.
29. Edlin M. Disease management, care guidelines win physician support. Health plans provide tools to assist doctors. Healthplan 2003;44(3):58-60.
30. Leider, H.L. HMOs need to share gains of DM programs. Managed Care 2001;10(7):33-4.
31. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Effect Clin Pract 1998;1(1):2-4.
32. Miller WR. Enhancing patient motivation for health behavior change [Editorial]. J Cardiopulm Rehab 2005;25(4):207-9.
33. Francis N, Rollnick S, McCambridge J, Butler C, Lane C, Hood K. When smokers are resistant to change: experimental analysis of the effect of patient resistance on practitioner behaviour. Addiction 2005;100:1175-82.
34. Linden A, Adams J, Roberts N. An assessment of the total population approach for evaluating disease management program effectiveness. Dis Manage 2003;6(2):93-102.
35. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to time series analysis. Dis Manage 2003;6(4):243-55.
36. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to survival analysis. Dis Manage 2004;7(3):180-90.
37. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness adjusting for enrollment (tenure) and seasonality. Res Healthc Fin Manage 2004;9(1):57-68.
38. Linden A, Adams J, Roberts N. Using propensity scores to construct comparable control groups for disease management program evaluation. Dis Manage and Healt Outc 2005;13(2):107-27.
39. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to the regression-discontinuity design. J Eval Clin Pract 2006;12(2):124-31.
40. Schrijvers G, Spreeuwenberg C, van der Laag H, et al. Disease Management in the Dutch Context. Utrecht, NL: Utrecht Publishing & Archiving Services, 2006.